Literature DB >> 2955418

Molecular events in the induction of a nonresponsive state in interleukin 2-producing helper T-lymphocyte clones.

M K Jenkins, D M Pardoll, J Mizuguchi, T M Chused, R H Schwartz.   

Abstract

Exposure of normal interleukin 2 (IL-2)-producing helper T-cell clones to antigen and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide-treated antigen-presenting cells results in proliferative unresponsiveness to subsequent stimulation with antigen and normal antigen-presenting cells. In the present study, we have examined the molecular events that accompany the induction of this unresponsive state. T cells stimulated in this manner failed to produce IL-2, but interleukin 3, interferon-gamma, and IL-2 receptors were partially induced and T-cell receptor beta mRNA was fully induced. Although T-cell unresponsiveness correlated with an IL-2 production defect, addition of IL-2 during the induction phase failed to prevent development of the unresponsive state. The critical biochemical event appeared to be an increase in intracellular calcium. Removal of calcium from the medium prevented induction of the unresponsive state, whereas addition of the calcium ionophore ionomycin induced unresponsiveness as well as all of the related partial activation events. Thus, an increase in intracellular calcium under nonmitogenic conditions appears to initiate an alternative activation program that prevents the T cell from producing IL-2 in response to subsequent normal activation signals. The significance of this in vitro model for tolerance induction in vivo is discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2955418      PMCID: PMC298867          DOI: 10.1073/pnas.84.15.5409

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

Review 1.  Inositol trisphosphate and diacylglycerol as second messengers.

Authors:  M J Berridge
Journal:  Biochem J       Date:  1984-06-01       Impact factor: 3.857

2.  Thymocytes appear to ignore class I major histocompatibility complex antigens expressed on thymus epithelial cells.

Authors:  H Von Boehmer; K Schubiger
Journal:  Eur J Immunol       Date:  1984-11       Impact factor: 5.532

3.  A new generation of Ca2+ indicators with greatly improved fluorescence properties.

Authors:  G Grynkiewicz; M Poenie; R Y Tsien
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

4.  The second messenger linking receptor activation to internal Ca release in liver.

Authors:  G M Burgess; P P Godfrey; J S McKinney; M J Berridge; R F Irvine; J W Putney
Journal:  Nature       Date:  1984 May 3-9       Impact factor: 49.962

5.  Identification and initial characterization of a rat monoclonal antibody reactive with the murine interleukin 2 receptor-ligand complex.

Authors:  T R Malek; R J Robb; E M Shevach
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

6.  Antigen presentation by human monocytes: evidence for stimulant processing and requirement for interleukin 1.

Authors:  G Scala; J J Oppenheim
Journal:  J Immunol       Date:  1983-09       Impact factor: 5.422

7.  Rapid accumulation of inositol trisphosphate reveals that agonists hydrolyse polyphosphoinositides instead of phosphatidylinositol.

Authors:  M J Berridge
Journal:  Biochem J       Date:  1983-06-15       Impact factor: 3.857

8.  Antigen presentation by resting B cells. Radiosensitivity of the antigen-presentation function and two distinct pathways of T cell activation.

Authors:  J D Ashwell; A L DeFranco; W E Paul; R H Schwartz
Journal:  J Exp Med       Date:  1984-03-01       Impact factor: 14.307

9.  Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin.

Authors:  J R Lamb; B J Skidmore; N Green; J M Chiller; M Feldmann
Journal:  J Exp Med       Date:  1983-05-01       Impact factor: 14.307

10.  Interleukin 2 upregulates expression of its receptor on a T cell clone.

Authors:  T R Malek; J D Ashwell
Journal:  J Exp Med       Date:  1985-06-01       Impact factor: 14.307

View more
  77 in total

Review 1.  Immunology of corneal transplantation.

Authors:  W H Constad; K Taraschanskiy
Journal:  Clin Rev Allergy Immunol       Date:  2001-04       Impact factor: 8.667

Review 2.  CD28, CTLA-4 and their ligands: who does what and to whom?

Authors:  D M Sansom
Journal:  Immunology       Date:  2000-10       Impact factor: 7.397

3.  Regulation of CD3-induced phospholipase C-gamma 1 (PLC gamma 1) tyrosine phosphorylation by CD4 and CD45 receptors.

Authors:  S B Kanner; J P Deans; J A Ledbetter
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

Review 4.  Molecular mechanisms for adaptive tolerance and other T cell anergy models.

Authors:  Seeyoung Choi; Ronald H Schwartz
Journal:  Semin Immunol       Date:  2007-04-02       Impact factor: 11.130

Review 5.  mTOR at the crossroads of T cell proliferation and tolerance.

Authors:  Anna Mondino; Daniel L Mueller
Journal:  Semin Immunol       Date:  2007-03-23       Impact factor: 11.130

Review 6.  T-cell costimulatory blockade in organ transplantation.

Authors:  Jonathan S Maltzman; Laurence A Turka
Journal:  Cold Spring Harb Perspect Med       Date:  2013-12-01       Impact factor: 6.915

Review 7.  Role of B7 signaling in the differentiation of naive CD4+ T cells to effector interleukin-4-producing T helper cells.

Authors:  W C Gause; J F Urban; P Linsley; P Lu
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

Review 8.  Calcium-NFAT transcriptional signalling in T cell activation and T cell exhaustion.

Authors:  Patrick G Hogan
Journal:  Cell Calcium       Date:  2017-01-28       Impact factor: 6.817

9.  "Anergy" of TH0 helper T lymphocytes induces downregulation of TH1 characteristics and a transition to a TH2-like phenotype.

Authors:  T F Gajewski; D W Lancki; R Stack; F W Fitch
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

10.  Inhibition of murine nephritogenic effector T cells by a clone-specific suppressor factor.

Authors:  C M Meyers; C J Kelly
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.